Paris, France

Bertrand Bellier


 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Bertrand Bellier: Innovator in Allergy and Autoimmune Disease Treatments

Introduction

Bertrand Bellier is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical innovations, particularly in the treatment of allergies and autoimmune diseases. With a total of 5 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents involves virus-like particles that can be used in the treatment of allergies. This invention relates to a virus-like particle comprising an allergen and an immunoregulatory molecule exposed on its surface. The invention also pertains to the use of this particle in the treatment of an allergy. Another notable patent focuses on virus-like particles for the treatment of autoimmune diseases. This invention includes a virus-like particle comprising an autoantigen and an immunoregulatory molecule exposed on its surface, along with its application in treating an autoimmune disease.

Career Highlights

Throughout his career, Bertrand Bellier has worked with esteemed institutions such as Sorbonne Université and Assistance Publique-Hôpitaux de Paris. His research and innovations have garnered attention in the scientific community, showcasing his dedication to advancing medical treatments.

Collaborations

He has collaborated with notable individuals in his field, including David Klatzmann and Jean-Loup Salzmann. These partnerships have further enriched his research and contributed to the development of his innovative patents.

Conclusion

In summary, Bertrand Bellier is a distinguished inventor whose work in developing virus-like particles for treating allergies and autoimmune diseases holds great promise. His contributions to medical science continue to pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…